B. SEER Educate - Core Competency 5: Cancer Program
Accreditation Standards Questions With Complete Solutions
According to the Standard, what type(s) of sampling strategy
must be specified in the quality control policy and procedure
methods section in selecting analytic cases for review?
Response:
A. Quota sampling
B. Judgement sampling
C. Both (A) and (B)
D. Neither (A) nor (B) Correct Answers D. Neither (A) nor (B)
Rationale:
According to Standard 6.1, a random sampling of annual
analytic caseload must be specified in the quality control policy
and procedure methods section. When using a random sampling
method, each case is chosen entirely by chance and each case in
the registry has an equal chance, or probability, of being
selected.
Non-probability (non-random) sampling methods such as quota
sampling and judgement sampling are not to be used. In non-
probability sampling, all cases are not included in the sampling
frame, so some cases have no chance of being selected.
Consequently, one cannot estimate the effect of sampling error
and there is a significant risk of ending up with a non-
representative sample which produces non-generalizable results.
At a General Multidisciplinary Cancer Case Conference, who is
required to attend?
Response:
A. Radiology
B. Psychosocial Providers
,C. Both (A) and (B)
D. Neither (A) nor (B) Correct Answers A. Radiology
Rationale:
Per Standard 2.5, the required multidisciplinary physician
attendance at a general cancer case conference must include a
representative from:
Surgery
Pathology
Radiology
Radiation Oncology
Medical Oncology
Additional physician or non-physician specialists recommended
for attendance are:
Genetic Professionals
Clinical Research Professionals
Palliative Care Professionals
Psychosocial Providers
Rehabilitation Providers
Supportive Services
For all eligible analytic cases, what is the minimum percent
follow-up rate for a Pediatric Cancer Programs (PCP) for a
rolling 15-year period from the most current year of completed
cases or the program's first accreditation date, whichever is
shorter?
Response:
A. 60%
B. 70%
C. 80%
,D. 90% Correct Answers -Per Standard 6.5, the cancer program
fulfills all of the compliance criteria by achieving these follow-
up rates:
For Pediatric Cancer Programs (PCP) facilities, a 60 percent
follow-up rate is maintained for all eligible analytic cases for a
rolling 15-year period from the most current year of completed
cases or the program's first accreditation date,
whichever is shorter.
-Per Standard 6.5, for all eligible cases, an 80 percent follow-up
rate is maintained for all eligible analytic cases from the most
current year of completed cases through 15 years before or the
program's first accreditation date, whichever is shorter.
-A 90 percent follow-up rate is maintained for all analytic cases
diagnosed from the most current year of completed cases
through five years before or the program's first accredited date,
whichever is shorter.
For CoC-accredited programs, which of the following are
eligible cancer pathology reports that need to be reported using
the College of American Pathologists (CAP) cancer protocols?
Response:
A. Diagnostic biopsies
B. Biomarker results
C. Both (A) and (B)
D. Neither (A) nor (B) Correct Answers D. Neither (A) nor (B)
Rationale:
According to Standard 5.1, for CoC-accredited programs,
"eligible cancer pathology reports" are defined as:
-Definitive surgical resection of primary invasive malignancies
and ductal carcinoma in situ (DCIS), and
, -Definitive surgical resection in patients who have received
neoadjuvant therapy AND who have residual tumor
The following do not need to be reported using the CAP Cancer
Protocols:
-Definitive surgical resection in which no residual tumor is
present
-Additional surgical procedure performed after definitive
resection (for example, resection of positive margins or node
biopsy/resection)
-Diagnostic biopsy, cytology specimens, or other diagnostic
procedures done before definitive surgical therapy
-Surgical resection for recurrent tumor
-In situ carcinomas (except for DCIS)
-Special studies (for example, biomarker or prognostic testing)
For physicians involved in the evaluation and management of
cancer patients, who does the physician credential Standard
apply to?
Response:
A. Physicians who are within the five years immediately
following graduation from a residency
B. Physicians at an accredited facility for at least one calendar
year who are not board certified but meet the continuing
education requirements of the Standard
C. Both (A) and (B)
D. Neither (A) nor (B) Correct Answers B.
Physicians at an accredited facility for at least one calendar year
who are not board certified but meet the continuing education
requirements of the Standard
Rationale:
Accreditation Standards Questions With Complete Solutions
According to the Standard, what type(s) of sampling strategy
must be specified in the quality control policy and procedure
methods section in selecting analytic cases for review?
Response:
A. Quota sampling
B. Judgement sampling
C. Both (A) and (B)
D. Neither (A) nor (B) Correct Answers D. Neither (A) nor (B)
Rationale:
According to Standard 6.1, a random sampling of annual
analytic caseload must be specified in the quality control policy
and procedure methods section. When using a random sampling
method, each case is chosen entirely by chance and each case in
the registry has an equal chance, or probability, of being
selected.
Non-probability (non-random) sampling methods such as quota
sampling and judgement sampling are not to be used. In non-
probability sampling, all cases are not included in the sampling
frame, so some cases have no chance of being selected.
Consequently, one cannot estimate the effect of sampling error
and there is a significant risk of ending up with a non-
representative sample which produces non-generalizable results.
At a General Multidisciplinary Cancer Case Conference, who is
required to attend?
Response:
A. Radiology
B. Psychosocial Providers
,C. Both (A) and (B)
D. Neither (A) nor (B) Correct Answers A. Radiology
Rationale:
Per Standard 2.5, the required multidisciplinary physician
attendance at a general cancer case conference must include a
representative from:
Surgery
Pathology
Radiology
Radiation Oncology
Medical Oncology
Additional physician or non-physician specialists recommended
for attendance are:
Genetic Professionals
Clinical Research Professionals
Palliative Care Professionals
Psychosocial Providers
Rehabilitation Providers
Supportive Services
For all eligible analytic cases, what is the minimum percent
follow-up rate for a Pediatric Cancer Programs (PCP) for a
rolling 15-year period from the most current year of completed
cases or the program's first accreditation date, whichever is
shorter?
Response:
A. 60%
B. 70%
C. 80%
,D. 90% Correct Answers -Per Standard 6.5, the cancer program
fulfills all of the compliance criteria by achieving these follow-
up rates:
For Pediatric Cancer Programs (PCP) facilities, a 60 percent
follow-up rate is maintained for all eligible analytic cases for a
rolling 15-year period from the most current year of completed
cases or the program's first accreditation date,
whichever is shorter.
-Per Standard 6.5, for all eligible cases, an 80 percent follow-up
rate is maintained for all eligible analytic cases from the most
current year of completed cases through 15 years before or the
program's first accreditation date, whichever is shorter.
-A 90 percent follow-up rate is maintained for all analytic cases
diagnosed from the most current year of completed cases
through five years before or the program's first accredited date,
whichever is shorter.
For CoC-accredited programs, which of the following are
eligible cancer pathology reports that need to be reported using
the College of American Pathologists (CAP) cancer protocols?
Response:
A. Diagnostic biopsies
B. Biomarker results
C. Both (A) and (B)
D. Neither (A) nor (B) Correct Answers D. Neither (A) nor (B)
Rationale:
According to Standard 5.1, for CoC-accredited programs,
"eligible cancer pathology reports" are defined as:
-Definitive surgical resection of primary invasive malignancies
and ductal carcinoma in situ (DCIS), and
, -Definitive surgical resection in patients who have received
neoadjuvant therapy AND who have residual tumor
The following do not need to be reported using the CAP Cancer
Protocols:
-Definitive surgical resection in which no residual tumor is
present
-Additional surgical procedure performed after definitive
resection (for example, resection of positive margins or node
biopsy/resection)
-Diagnostic biopsy, cytology specimens, or other diagnostic
procedures done before definitive surgical therapy
-Surgical resection for recurrent tumor
-In situ carcinomas (except for DCIS)
-Special studies (for example, biomarker or prognostic testing)
For physicians involved in the evaluation and management of
cancer patients, who does the physician credential Standard
apply to?
Response:
A. Physicians who are within the five years immediately
following graduation from a residency
B. Physicians at an accredited facility for at least one calendar
year who are not board certified but meet the continuing
education requirements of the Standard
C. Both (A) and (B)
D. Neither (A) nor (B) Correct Answers B.
Physicians at an accredited facility for at least one calendar year
who are not board certified but meet the continuing education
requirements of the Standard
Rationale:
